Group One Trading’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-200
| Closed | -$22K | – | 7362 |
|
|
2020
Q3 | $22K | Sell |
200
-500
| -71% | -$53.7K | ﹤0.01% | 5094 |
|
|
2020
Q2 | $72K | Buy |
+700
| New | +$74.9K | ﹤0.01% | 4142 |
|
|
2020
Q1 | – | Sell |
-14,000
| Closed | -$1.63M | – | 6145 |
|
|
2019
Q4 | $1.63M | Sell |
14,000
-31,100
| -69% | -$3.6M | 0.01% | 1460 |
|
|
2019
Q3 | $5.16M | Sell |
45,100
-6,200
| -12% | -$616K | 0.04% | 553 |
|
|
2019
Q2 | $4.89M | Buy |
51,300
+32,400
| +171% | +$3.05M | 0.04% | 532 |
|
|
2019
Q1 | $1.73M | Sell |
18,900
-4,800
| -20% | -$393K | 0.02% | 1029 |
|
|
2018
Q4 | $1.8M | Buy |
23,700
+7,900
| +50% | +$581K | 0.02% | 1109 |
|
|
2018
Q3 | $1.26M | Buy |
15,800
+13,300
| +532% | +$1.24M | 0.01% | 1509 |
|
|
2018
Q2 | $248K | Buy |
+2,500
| New | +$216K | ﹤0.01% | 2892 |
|
|
2017
Q3 | – | Sell |
-10,000
| Closed | -$1.13M | – | 5526 |
|
|
2017
Q2 | $1.13M | Sell |
10,000
-10,000
| -50% | -$1.12M | 0.01% | 1354 |
|
|
2017
Q1 | $2M | Buy |
20,000
+13,500
| +208% | +$1.44M | 0.02% | 867 |
|
|
2016
Q4 | $699K | Buy |
6,500
+200
| +3% | +$23.4K | 0.01% | 1557 |
|
|
2016
Q3 | $784K | Hold |
6,300
| – | – | 0.01% | 1453 |
|
|
2016
Q2 | $670K | Buy |
6,300
+4,200
| +200% | +$488K | 0.01% | 1526 |
|
|
2016
Q1 | $240K | Sell |
2,100
-3,900
| -65% | -$458K | ﹤0.01% | 2206 |
|
|
2015
Q4 | $855K | Buy |
6,000
+1,900
| +46% | +$219K | 0.01% | 1410 |
|
|
2015
Q3 | $368K | Buy |
4,100
+4,000
| +4,000% | +$422K | 0.01% | 2021 |
|
|
2015
Q2 | $12K | Sell |
100
-900
| -90% | -$94.6K | ﹤0.01% | 4247 |
|
|
2015
Q1 | $96K | Buy |
+1,000
| New | +$74.8K | ﹤0.01% | 2931 |
|
Group One Trading's CBPO Position: Q2 2021 in Review
Group One Trading sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 285 shares — an estimated $34K sold.
Group One Trading first reported a position in CBPO in Q3 2015 and held it in 13 quarters. The position peaked at $8.01M in Q3 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Group One Trading reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Group One Trading sold 285 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $34K.
- Group One Trading first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 13 quarters.
- Group One Trading's China Biologic Products Holdings, Inc. position peaked at $8.01M in Q3 2019.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.